Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1111531C details a scalable xylene-based process for castanospermine esters, offering significant cost reduction in pharma manufacturing and enhanced supply reliability.
Patent CN110540975B reveals high-efficiency biocatalytic route for sitagliptin precursors, offering superior stereoselectivity and reduced environmental impact for pharma supply chains.
Patent CN112707919B introduces a graphene-supported copper catalyst for synthesizing 3-decarbamoyl cefuroxime acid, offering high purity and reduced phosphorus waste.
Patent CN116396950A reveals a novel carboxylesterase mutant for efficient (R)-3-cyclohexene-1-carboxylic acid production, offering superior stereoselectivity and scalable biocatalysis for API intermediates.
Patent CN100379733C reveals a high-yield synthesis for triazole antifungal intermediates. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN104926802B details improved synthesis for neuraminic acid derivatives offering enhanced purity and operational efficiency for global pharmaceutical intermediate supply chains.
Patent CN111875591B details a green one-pot synthesis for benzopyrone intermediates using recyclable ionic liquids, offering significant cost and purity advantages for pharmaceutical manufacturing.
Advanced continuous flow synthesis for ethyl 6-oxo-8-chlorooctanoate. A key lipoic acid intermediate offering high yield, superior purity, and scalable manufacturing solutions.
Patent CN101747304B reveals a green Zn/PEG/H2O method for vinyl sugar synthesis, offering high yields and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN108659094A reveals efficient Mycoleptodiscin A synthesis. Enables cost reduction in fine chemical manufacturing and reliable supply chain for high-purity intermediates.
Advanced oxidation method for 2-nitro-4-methylsulfonylbenzoic acid intermediates. Reduces catalyst toxicity and improves supply chain reliability for global pharmaceutical manufacturing.
Patent CN111549008B reveals a novel AcATA mutant for sitagliptin intermediate synthesis, offering superior conversion rates and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN111549008B reveals a novel AcATA mutant for sitagliptin intermediates. Achieves 90% conversion with superior purity and reduced environmental impact for pharma supply chains.
Patent CN118374465B reveals enzymatic route for (S)-nicotine. Achieves 99.1% ee value. Offers scalable biocatalysis for reliable pharmaceutical intermediates supplier chains.
Novel lipase mutant enhances Pregabalin intermediate synthesis efficiency and purity. Cost-effective biocatalytic solution for pharmaceutical manufacturing supply chains.
Patent CN105734028A reveals high-efficiency epoxide hydrolase mutants for R-epichlorohydrin production, offering superior stability and supply chain reliability.
Patent CN111689881A reveals a catalytic sulfonation method for 4-chloro-2-fluoro-5-sulfamoylbenzoic acid, offering high purity and yield for reliable pharmaceutical intermediate supply chains.
Patent CN105734028A reveals mutant epoxide hydrolase for high-purity R-epichlorohydrin. Enhances stability and activity for reliable pharmaceutical intermediate supply chains.
Novel patent CN108659031A offers mild conditions for eribulin intermediate. Enhances supply chain reliability and reduces manufacturing costs for pharma partners.
Patent CN108026130B reveals enzyme mutant method for NMN. Low cost, high purity, scalable supply chain solution for global buyers.